Good evening :)
Place Order
Add to Watchlist

Shree Ganesh Remedies Ltd

SGRL

Shree Ganesh Remedies Ltd

SGRL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹929 cr, stock is ranked 1,527
High RiskStock is 3.34x as volatile as Nifty
749.000.65% (+4.85)
749.000.65% (+4.85)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹929 cr, stock is ranked 1,527
High RiskStock is 3.34x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹929 cr, stock is ranked 1,527
High RiskStock is 3.34x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
33.407.620.07%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.536.560.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Shree Ganesh Remedies Limited is engaged in manufacturing and dispatching of drug intermediates and chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions etc.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2024TTM
Total Revenue128.97118.51
Raw Materialssubtract63.3673.43
Power & Fuel Costsubtract6.39
Employee Costsubtract8.41
Selling & Administrative Expensessubtract9.42
Operating & Other expensessubtract-3.49
Depreciation/Amortizationsubtract6.117.29
Interest & Other Itemssubtract0.610.95
Taxes & Other Itemssubtract10.059.00
EPS21.8821.67
DPS0.500.00
Payout ratio0.020.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

Jul 13PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Shree Ganesh Remedies Ltd33.087.620.07%
Sun Pharmaceutical Industries Ltd45.356.470.75%
Cipla Ltd28.514.380.89%
Torrent Pharmaceuticals Ltd68.4516.540.84%

Price Comparison

Compare SGRL with any stock or ETF
Compare SGRL with any stock or ETF
SGRL
Loading...

Shareholdings

Promoter Holdings Trend

Increased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.16%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.50%0.00%0.00%0.01%29.50%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.01%0.01%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 7, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 7, 2023

Cash Dividend

Ex DateEx DateSep 15, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 15, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹1.75

Dividend/Share

1.75

Ex DateEx Date

Sep 8, 2021

Cash Dividend

Ex DateEx DateSep 1, 2020

Final
Final | Div/Share: ₹1.50

Dividend/Share

1.50

Ex DateEx Date

Sep 1, 2020

Cash Dividend

Ex DateEx DateAug 22, 2019

Final
Final | Div/Share: ₹1.25

Dividend/Share

1.25

Ex DateEx Date

Aug 22, 2019

News & Opinions
Earnings
Shree Ganesh Remedies standalone net profit declines 1.98% in the September 2024 quarter

Net profit of Shree Ganesh Remedies declined 1.98% to Rs 6.42 crore in the quarter ended September 2024 as against Rs 6.55 crore during the previous quarter ended September 2023. Sales declined 3.26% to Rs 32.33 crore in the quarter ended September 2024 as against Rs 33.42 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.3333.42 -3 OPM %34.9827.59 - PBDT11.0710.01 11 PBT8.658.60 1 NP6.426.55 -2 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Shree Ganesh Remedies to declare Quarterly Result

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Shree Ganesh Remedies AGM scheduled

Shree Ganesh Remedies announced that the 29th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Shree Ganesh Remedies announces board meeting date

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 28 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Shree Ganesh Remedies standalone net profit rises 2.42% in the June 2024 quarter

Net profit of Shree Ganesh Remedies rose 2.42% to Rs 4.65 crore in the quarter ended June 2024 as against Rs 4.54 crore during the previous quarter ended June 2023. Sales declined 7.26% to Rs 24.78 crore in the quarter ended June 2024 as against Rs 26.72 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.7826.72 -7 OPM %32.8524.59 - PBDT8.367.29 15 PBT6.346.27 1 NP4.654.54 2 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Shree Ganesh Remedies announces board meeting date

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live